Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure

被引:8
|
作者
Zamorskii, I. I. [1 ]
Shchudrova, T. S. [1 ]
Lin'kova, N. S. [3 ,4 ]
Nichik, T. E. [4 ]
Khavinson, V. Kh. [2 ,3 ]
机构
[1] Bukovinian State Med Univ, Chernovtsy, Ukraine
[2] II Mechnikov North Western State Med Univ, St Petersburg, Russia
[3] St Petersburg State Polytech Univ, St Petersburg, Russia
[4] St Petersburg Inst Bioregulat & Gerontol, St Petersburg, Russia
关键词
acute renal failure; cisplatin; peptides; NEPHROTOXICITY; MECHANISMS;
D O I
10.1007/s10517-015-3062-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of polypeptide complex from the kidney and short peptides AED, EDL, and AEDG on renal functions were studied in rats with cisplatin-induced acute renal failure. AED peptide decreased protein excretion and electrolyte concentration in the urine. Polypeptide complex from the kidney and peptides EDL and AEDG normalized diuresis, creatinine concentration in the urine and its excretion, glomerular filtration rate, and absolute resorption of sodium ions and reduced protein concentration in the urine and its excretion, the concentrations of sodium and potassium ions in the urine, and other parameters. EDL peptide produced was potent nephroprotective effect. It is known that the polypeptide complex of the kidney and short peptides restore the expression of signal molecules (marker of functional state of the kidneys), so these peptide substances can have nephroprotective effect during various renal pathologies.
引用
收藏
页码:736 / 739
页数:4
相关论文
共 50 条
  • [31] Mitochondrial dysfunction at the early stage of cisplatin-induced acute renal failure in rats
    Xie Li-ping
    C. Skrezek
    H. Wand
    F. Reibe
    Journal of Zhejiang University-SCIENCE A, 2000, 1 (1): : 91 - 96
  • [32] PPARα ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity
    Li, SY
    Wu, PF
    Yarlagadda, P
    Vadjunec, NM
    Proia, AD
    Harris, RA
    Portilla, D
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (03) : F572 - F580
  • [33] Nephroprotective Activity of Prosthechea michuacana Against Cisplatin-Induced Acute Renal Failure in Rats
    Perez Gutierrez, Rosa Martha
    Gomez y Gomez, Yolanda
    Bautista Ramirez, Esther
    JOURNAL OF MEDICINAL FOOD, 2010, 13 (04) : 911 - 916
  • [34] URINARY GLUTATHIONE-S-TRANSFERASE IN CISPLATIN-INDUCED ACUTE-RENAL-FAILURE
    FEINFELD, D
    FUH, V
    SAFIRSTEIN, R
    CLINICAL RESEARCH, 1984, 32 (02): : A414 - A414
  • [35] EFFECT OF THE ANF ANALOG A68828 IN CISPLATIN-INDUCED ACUTE-RENAL-FAILURE
    POLLOCK, DM
    HOLST, M
    OPGENORTH, TJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 257 (03): : 1179 - 1183
  • [36] Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner
    Özyurt, H
    Yildirim, Z
    Kotuk, M
    Yilmaz, HR
    Yagmurca, M
    Iraz, M
    Sögüt, S
    Gergerlioglu, S
    JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (04) : 269 - 275
  • [37] Role of the increase in p21 in cisplatin-induced acute renal failure in rats
    Miyaji, T
    Kato, A
    Yasuda, H
    Fujigaki, Y
    Hishida, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (05): : 900 - 908
  • [38] Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure
    Linkermann, Andreas
    Himmerkus, Nina
    Roelver, Lars
    Keyser, Kirsten A.
    Steen, Philip
    Braesen, Jan-Hinrich
    Bleich, Markus
    Kunzendorf, Ulrich
    Krautwald, Stefan
    KIDNEY INTERNATIONAL, 2011, 79 (02) : 169 - 178
  • [39] Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death
    Zhou, H
    Miyaji, T
    Kato, A
    Fujigaki, Y
    Sano, K
    Hishida, A
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (06): : 649 - 658
  • [40] Cisplatin-induced acute renal failure is accelerated in interleukin-6 knockout mice
    Mitazaki, Satoru
    Kato, Naho
    Suto, Miwako
    Hiraiwa, Kouichi
    Abe, Sumiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 148P - 148P